Organiser Name: Hanson Wade
Contact: Anita Kelemen
The 7th Liquid Biopsy for Precision Oncology Summit returns as the largest and most comprehensive forum for all stakeholders in the field to tap into the promising opportunities that revolutionize the entire cancer patient care continuum from early translation all the way through to clinical development and commercialization.
Expect exclusive data from KOLs on the most recent developments in the utilization of liquid biopsies for early detection, prognosis and treatment. Join 200+ pioneers from the likes of Pfizer, AstraZeneca, BloodPAC, NuProbe and many more as we explore key scientific, technical, regulatory and commercial challenges associated with progressing precision oncology pipelines harnessing liquid biopsies.